•Clinical characteristics of patients with overlapping eosinophilic esophagitis and inflammatory bowel disease in a national real-world cohort
•Smart Oral Capsule with a Closed-Loop Sense-Decide-Act Strategy for Colitis Therapy
•Platelet P2Y12 inhibitor use and risk of colorectal cancer incidence and colorectal cancer-related mortality: a Swedish registry-based cohort study
•Comparison of the efficacy of TXNDC5 monoclonal antibody versus conventional drugs in the treatment of intestinal fibrosis associated with inflammatory bowel disease
•Reconsidering therapeutic strategies after biologic failure in ulcerative colitis: appendectomy versus Janus kinase inhibition
